Literature DB >> 23774646

Chemotherapy: Supplements--for better or worse?

Lisa Hutchinson.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23774646     DOI： 10.1038/nrclinonc.2013.106

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Lori M Minasian; Danielle Awad; Carol M Moinpour; Lisa Hansen; Danika L Lew; Heather Greenlee; Louis Fehrenbacher; James L Wade; Siu-Fun Wong; Gabriel N Hortobagyi; Frank L Meyskens; Kathy S Albain
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.